MCW LaBahn Pancreatic Cancer Program

We are so grateful to Debbie and Mark Attanasio for their pledge to support pancreatic cancer research at MCW, honoring Bob Uecker's legacy. Their gift will advance research and drive progress in the fight against .

MCW Department of Surgery

🍕🌮There's still time to grab some delicious bites 🍜at our event! Join us until 2 PM today and help raise awareness for Pancreatic Cancer.

Romero’s Taco Truck, Pop's BBQ - Milwaukee, Chillwaukee, Jess Peachy, Hot Box Pizza MKE

MCW Department of Surgery, Medical College of Wisconsin Cancer Center

🎊Dr. Nikki Lytle (PI) & Priyanga Jayakrishnan (CO-I) 🥳have been awarded the Matthew J. Rise, MD, PHD Promising Pilot Grant. The grant was given for her work on the systematic targeting of Midkine as a new method to prevent liver metastasis in cancer.

🚀 Exciting news! 🎉 Check out this inspiring interview with former Medical Director of the Milwaukee Brewers and a pancreatic cancer survivor. 🙌 He’s now rallying to raise funds and support our program. We are thankful for his efforts🌟
Seena Magowitz Pancreatic Cancer Foundation, Fox News, MCW Department of Surgery, Medical College of Wisconsin Cancer Center

Former Brewers medical VP still fighting for others from the field “When I was diagnosed it was like, man, I’m shocked. But I analyze the curveball. All right, you see a hanging curveball’s here and people take those, right? I chose to hit it out of the park."

🙏We are so thankful to Florida Panthers GM Bill Zito for bringing the Stanley Cup🏆 yesterday! His visit supports our efforts in pancreatic cancer research🔬 and raises vital awareness for this critical cause. 💜💜💜

MCW Department of Surgery

💜

'I feel very fortunate': Former Brewers medical director advocates for pancreatic cancer research MILWAUKEE (CBS 58) – The former medical director for the Milwaukee Brewers is raising awareness of pancreatic cancer, and he helped facilitate a historic gathering on the field over the weekend.Roger Caplinger

Mark your calendars!

The LaBahn Pancreatic Cancer Program will be hosting a Food Truck Fundraiser on Wednesday, August 21 next to the MCW Hub from 11:00am - 2:00pm!

Check out who will be joining us!






Pop's BBQ

Join us for this half-day event:

MCW Pancreatic Cancer Symposium: Bench to Bedside

Friday, August 2nd, 2024 📅
12:00 PM - 4:30 PM

Register Here:

bit.ly/PANCSYMPOSIUM

In a groundbreaking new study, Medical College of Wisconsin scientists unveiled a promising path to treating pancreatic ductal adenocarcinoma (PDAC), identifying four distinct subtypes based on their tumor microenvironment (TME) immune composition.

PDAC has long been notorious for its aggressive nature and genetic complexity, making it difficult for doctors to predict how patients will respond to treatment. These novel findings, published in Gastroenterology, may open the door to the development of cutting-edge strategies.

Learn more: https://cancer.mcw.edu/stories/mcw-scientists-identify-patients-with-pancreatic-cancer-who-may-respond-to-immunotherapy

Drs. Callisia Clarke and Ronald P. DeMatteo are thrilled to share how previous SSO sessions have made a positive impact on fellows and residents! 🚀

Watch here:
bit.ly/SSOCLARKE

Medical College of Wisconsin investigators have opened PROTECT-PANC, an innovative , led by Dr. Mandana Kamgar, that evaluates strategies in patients with at a high risk of disease recurrence post-surgery.

While is well-known for its excellence in treating patients within the MCW LaBahn Pancreatic Cancer Program, the inherent chemotherapy- and radiation-resistant nature of the disease still results in many patients who experience recurrence after surgery. PROTECT-PANC provides an individualized, chemotherapy-free treatment for patients, and bolsters MCW’s dedication to advancing precision medicine strategies across a wide spectrum of cancer types.

Learn more: https://clinicaltrials.gov/study/NCT06228599?intr=NCT06228599&rank=1

👀NEW clinical trial! This is a prospective, open-label, therapeutic interventional trial aimed to determine the efficacy & safety of personalized matched therapy given adjuvantly in pancreatic cancer patients.

More info:
http://bit.ly/PRpanc

Sponsor:
Seena Magowitz Pancreatic Cancer Foundation